Drive faster, more confident decisions in drug development

Discover how researchers are uncovering predictive biomarkers, validating targets, and improving trial outcomes using high-plex proteomic data. The Biomarkers case studies collection highlights six real-world examples from aging and cardiovascular research to NASH clinical trials, showing how the SomaScan™ Platform delivers actionable insights across every stage of drug development.

You’ll learn about:

• How high-plex proteomics reveals novel biomarkers missed by conventional technologies
• Real-world strategies for accelerating go/no-go decisions using pharmacodynamic fingerprints
• How predictive proteomic models improve patient stratification and reduce clinical trial failure rate
• How surrogate endpoints built on  the SomaScan Platform data shorten timelines and enhance regulatory confidence
• Examples of translating proteomic signatures from discovery to clinical utility across diverse therapeutic areas
• How researchers are using noninvasive blood-based assays to monitor treatment response and disease progression in real time